Latest News

Intranasal ketamine confers rapid antidepressant effect in depression

The first controlled evidence has been released showing that an intranasal ketamine spray conferred an unusually rapid antidepressant effect ?- within 24 hours ?- and was well tolerated in patients with treatment-resistant major depressive disorder. One of the most common NMDA receptor antagonists, ketamine is an FDA-approved anesthetic. It has been used in animals and humans for years. Ketamine has also been a drug of abuse and can lead to untoward psychiatric or cognitive problems when misused. In low doses, ketamine shows promise in providing rapid relief of depression, with tolerable side effects.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • It doesn't 'get better' for some bullied LGBT youths

  • COPD may cause structural changes within the brain

  • Renal denervation helps to bring drug-resistant hypertension under control, rat study shows

  • Older and younger adults surf different brain waves

  • Brain scars in multiple sclerosis patients reveal possible cause of taste problems

  • Origin of sighing reflex in the brain pinpointed

  • New device to get people with paralysis back on their feet

  • Cocaine users present alterations in function, structures of brain

  • Sustained aerobic exercise increases adult neurogenesis in brain

  • The significance of non-motor microtubule-associated protein in maintaining synaptic plasticity thorough a novel mechanism

  •